期刊： CURRENT PHARMACEUTICAL DESIGN, 2023; 29 (17)
Introduction We report herein on the design and development of matrix tablets containing potent synthetic melatonin (MLT) receptor analogues, the x-fl......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2023; 29 (4)
Neurodegenerative diseases are chronic and progressive disease groups characterized by the decline of neural transmission because of the loss of struc......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2023; 29 (31)
Background: microRNA-628-5p (miR-628-5p) has a significant impact on certain types of cancer. The precise function of miR-628-5p in the context of bla......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2023; 29 (15)
Icacinaceae, an Angiospermic family comprising 35 genera and 212 accepted species, including trees, shrubs, and lianas with pantropical distribution, ......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2023; 29 (41)
This review highlights the relationships between gastrointestinal microorganisms and the brain. The gut microbiota communicates with the central nervo......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2023; 29 (38)
Introduction: The monkeypox virus has emerged as an uncommon zoonotic infection. The recent outbreak of MPXV in Europe and abroad in 2022 presented a ......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2023; 29 (13)
Microsponges are polymeric delivery devices composed of porous microspheres that range in size from 5 to 300 micrometers. These have been explored for......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2023; 29 (23)
Objective: This study aimed to determine the effectiveness and safety of 5 mg olanzapine (OLZ) in preventing vomiting and nausea caused by carboplatin......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2023; 29 (31)
Background Coronavirus disease 2019 (COVID-19) not only causes a range of respiratory symptoms but also has a great impact on individual mental health......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2023; 29 (31)
Background The release of a product in the consumer market requires an analysis by quality control. This sector makes use of reliable analytical metho......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2023; 29 (13)
Rheumatoid arthritis (RA) is the most common form of the chronic inflammatory autoimmune disease characterized by chronic synovitis, synovial prolifer......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2023; 29 (22)
Aims The fight against cancer is an active research topic that combines several disciplines to find suitable agents to treat various tumours.Backgroun......
